Pragma Market Research


Cancer Therapeutics Market, By Types (Prostate Cancer, Blood Cancer, Lung Cancer, Skin Cancer, Gastrointestinal Cancer, Breast Cancer, And Others), By Therapy (Chemotherapy, Hormonal, Immunotherapy, Targeted Therapy And Other) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) ? Analysis, Share, Trends, Size, & Forecast From 2023-2032

Cancer Therapeutics Market, By Types (Prostate Cancer, Blood Cancer, Lung Cancer, Skin Cancer, Gastrointestinal Cancer, Breast Cancer, And Others), By Therapy (Chemotherapy, Hormonal, Immunotherapy, Targeted Therapy And Other) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) ? Analysis, Share, Trends, Size, & Forecast From 2023-2032
Report Category: Pharma and Healthcare
SKU: PMR-119300  Published Date: 2023-10-21   Pages:190   Delivery Format:


CHOOSE LICENSE TYPE





PMR Research.

Market Executive Summary

The global market for cancer therapeutics is projected to reach approximately US$ 392 billion by the year 2032, up from US$ 163 billion in 2022, exhibiting a compound annual growth rate (CAGR) of 9.19% during the forecast period from 2023 to 2032.



Cancer therapeutics is defined as the non-surgical or non-radiotherapeutic management of patients suffering from cancer. It’s a combined discipline of medical oncology. The cancer therapeutics are available for various types of cancer including blood cancer, lung cancer, colorectal cancer, prostate cancer, breast cancer, cervical cancer, head and neck cancer, glioblastoma, malignant meningioma, mesothelioma, melanoma, and others. In addition, various types of treatment are available for cancer including chemotherapy, targeted therapy, immunotherapy, hormonal therapy, and others. The users of these therapeutics include hospitals, specialty clinics, and cancer and radiation therapy centers. According to the World Health Organization (WHO), in 2018, cancer was responsible for an estimated 9.6 million deaths globally. Also, cancer is estimated as the second leading cause of death across the globe and about 1 in 6 deaths is due to cancer. In addition, approximately 70% of deaths from cancer occur in low and middle-income countries.



Market Dynamics



The rising prevalence of cancer across the globe due to changing lifestyle is primarily driving the market growth. Increasing initiatives for cancer awareness by several governments worldwide is accelerating market growth. Ongoing R&D activities by major players along with increasing Patient Assistance Programs (PAPs), rising strategic acquisitions & collaborations of key market players are further accelerating the market value.



On the flip side, the high cost associated with the drug development and adverse effects of cancer drug therapy in some cases is likely to hamper the market growth. Fluctuation in reimbursement policies is also anticipated to hinder the market value. Whereas, high potential associated with personalized medicines and increasing purchasing power of emerging economies is expected to create potential opportunities over the forecast period.



Application Stance



By application, breast cancer is leading the segment in the year 2018 and the segment is also anticipated to maintain its dominance over the forecast period. The rapidly changing lifestyle of women across the globe is accelerating the demand in the market. According to the US National Cancer Institute, the most common cancer estimated in the year 2018 is breast cancer among all estimated new cases of the respective year.



Treatment Type Stance



On the basis of treatment type, targeted therapy is estimated to be the largest market share over in the year 2018 and the segment is also anticipated to maintain its dominance over the forecast period. The advantages associated with targeted therapy include minimal harm to normal cells, fewer side effects, improved effectiveness, and improved quality of life. In addition, specific proteins or genes are blocked in targeted therapy that prevents cancer cells growth and metastasis which is also a factor accelerating market growth.



The market research study on “Cancer Therapeutics Market”, offers a detailed insight on the global cancer therapeutics market entailing insights on its different market segments. Market dynamics with drivers, restraints, and opportunities with their impact are provided in the report. The report provides insights into the global Cancer Therapeutics market, its treatment type, application, and major geographic regions. The report covers basic development policies and layouts of technology development processes. Secondly, the report covers the global Cancer Therapeutics market size and volume, and segment markets by product type, application, and geography along with the information on companies operating in the market. The Cancer Therapeutics market analysis is provided for major regional markets including North America, Europe, Asia Pacific, Latin America and Middle East and Africa. For each region, the market size and volume for different segments has been covered under the scope of report.



In 2018, North America dominated the regional market with largest share of cancer therapeutics market. The market is also anticipated to maintain its dominance over the forecast period from 2019 to 2026. The region is experiencing high growth owing to the high prevalence of cancer in the major countries of the region. The increasing adoption of cancer therapies is accelerating the market growth. According to the National Cancer Institute (NCI) US, in 2018, around 1,735,350 new cases were diagnosed with cancer in the US, and approx. 609,640 people died from the disease. Additionally, according to NCI in 2017, an estimated 15,270 children and adolescents between the age of 0 to 19 were diagnosed with cancer and 1,790 died of the disease. The most common cancers arranged in descending order according to estimated new cases in 2018 are breast cancer, lung and bronchus cancer, prostate cancer, colon and rectum cancer, melanoma of the skin, bladder cancer, non-Hodgkin lymphoma, kidney and renal pelvis cancer, endometrial cancer, leukemia, pancreatic cancer, thyroid cancer, and liver cancer.



The players profiled in the report are AbbVie Inc., Astellas Pharma Inc., Bristol Myers Squibb Company, Celgene Corporation, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co., Inc., Novartis AG, Pfizer Inc. and others. The major players are involved in mergers & acquisition and partnership for expanding the market share.



Market Segmentation



Market By Application




  • Blood Cancer

  • Lung Cancer

  • Colorectal Cancer

  • Prostate Cancer

  • Breast Cancer

  • Cervical Cancer

  • Head and Neck Cancer

  • Glioblastoma

  • Malignant Meningioma

  • Mesothelioma

  • Melanoma

  • Others



Market By Treatment Type




  • Chemotherapy

  • Targeted Therapy

  • Immunotherapy

  • Hormonal Therapy

  • Others



Market By Geography




  • North America

    • US

    • Canada



  • Europe

    • UK

    • Germany

    • France

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Latin America

    • Brazil

    • Mexico

    • Rest of Latin America



  • Middle East & Africa

    • GCC

    • South Africa

    • Rest of Middle East & Africa





Table of Contents

Table Of Content



CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope

   1.1.1. Definition of Cancer Therapeutics

   1.1.2. Market Segmentation

   1.1.3. List of Abbreviations

1.2. Summary

   1.2.1. Market Snapshot

   1.2.2. Cancer Therapeutics Market By Application

     1.2.2.1. Global Cancer Therapeutics Market Revenue and Growth Rate Comparison By Application (2015-2026)

     1.2.2.2. Global Cancer Therapeutics Market Revenue Share By Application in 2018

     1.2.2.3. Blood Cancer

     1.2.2.4. Colorectal Cancer

     1.2.2.5. Prostate Cancer

     1.2.2.6. Breast Cancer

     1.2.2.7. Cervical Cancer

     1.2.2.8. Head and Neck Cancer

     1.2.2.9. Glioblastoma

     1.2.2.10. Malignant Meningioma

     1.2.2.11. Mesothelioma

     1.2.2.12. Melanoma

     1.2.2.13. Others

   1.2.3. Cancer Therapeutics Market By Treatment Type

     1.2.3.1. Global Cancer Therapeutics Market Revenue and Growth Rate Comparison By Treatment Type (2015-2026)

     1.2.3.2. Global Cancer Therapeutics Market Revenue Share By Treatment Type in 2018

     1.2.3.3. Chemotherapy

     1.2.3.4. Targeted Therapy

     1.2.3.5. Immunotherapy

     1.2.3.6. Hormonal Therapy

     1.2.3.7. Others

   1.2.4. Cancer Therapeutics Market By Geography

     1.2.4.1. Global Cancer Therapeutics Market Revenue and Growth Rate Comparison by Geography (2015-2026)

     1.2.4.2. North America Cancer Therapeutics Market Revenue and Growth Rate (2015-2026)

     1.2.4.3. Europe Cancer Therapeutics Market Revenue and Growth Rate (2015-2026)

     1.2.4.4. Asia-Pacific Cancer Therapeutics Market Revenue and Growth Rate (2015-2026)

     1.2.4.5. Latin America Cancer Therapeutics Market Revenue and Growth Rate (2015-2026)

     1.2.4.6. Middle East and Africa (MEA) Cancer Therapeutics Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers

2.2. Restraints and Challenges

2.3. Growth Opportunities

2.4. Porter’s Five Forces Analysis

   2.4.1. Bargaining Power of Suppliers

   2.4.2. Bargaining Power of Buyers

   2.4.3. Threat of Substitute

   2.4.4. Threat of New Entrants

   2.4.5. Degree of Competition

2.5. Value Chain Analysis

2.6. Cost Structure Analysis

   2.6.1. Raw Material and Suppliers

   2.6.2. Manufacturing Process Analysis

2.7. Regulatory Compliance

2.8. Competitive Landscape, 2018

   2.8.1. Player Positioning Analysis

   2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Cancer Therapeutics Major Manufacturers in 2018

3.2. Manufacturing Plants Distribution of Global Cancer Therapeutics Major Manufacturers in 2018

3.3. R&D Status and Technology Source of Global Cancer Therapeutics Major Manufacturers in 2018

3.4. Raw Materials Sources Analysis of Global Cancer Therapeutics Major Manufacturers in 2018

CHAPTER 4. CANCER THERAPEUTICS MARKET BY APPLICATION

4.1. Global Cancer Therapeutics Revenue By Application

4.2. Blood Cancer

   4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

   4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.3. Lung Cancer

   4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

   4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.4. Colorectal Cancer

   4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

   4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.5. Prostate Cancer

   4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

   4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.6. Breast Cancer

   4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

   4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.7. Cervical Cancer

   4.7.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

   4.7.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.8. Head and Neck Cancer

   4.8.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

   4.8.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.9. Glioblastoma

   4.9.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

   4.9.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.10. Malignant Meningioma

   4.10.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

   4.10.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.11. Mesothelioma

   4.11.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

   4.11.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.12. Melanoma

   4.12.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

   4.12.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

4.13. Others

   4.13.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

   4.13.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. CANCER THERAPEUTICS MARKET BY TREATMENT TYPE

5.1. Global Cancer Therapeutics Revenue By Treatment Type

5.2. Chemotherapy

   5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

   5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

5.3. Targeted Therapy

   5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

   5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

5.4. Immunotherapy

   5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

   5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

5.5. Hormonal Therapy

   5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

   5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

5.6. Others

   5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)

   5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA CANCER THERAPEUTICS MARKET BY COUNTRY

6.1. North America Cancer Therapeutics Market Revenue and Growth Rate, 2015 - 2026 ($Million)

6.2. North America Cancer Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)

6.3. U.S.

   6.3.1. U.S. Cancer Therapeutics Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

   6.3.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

6.4. Canada

   6.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

   6.4.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE CANCER THERAPEUTICS MARKET BY COUNTRY

7.1. Europe Cancer Therapeutics Market Revenue and Growth Rate, 2015 - 2026 ($Million)

7.2. Europe Cancer Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)

7.3. UK

   7.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

   7.3.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

7.4. Germany

   7.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

   7.4.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

7.5. France

   7.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

   7.5.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

7.6. Spain

   7.6.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

   7.6.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

7.7. Rest of Europe

   7.7.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

   7.7.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC CANCER THERAPEUTICS MARKET BY COUNTRY

8.1. Asia-Pacific Cancer Therapeutics Market Revenue and Growth Rate, 2015 - 2026 ($Million)

8.2. Asia-Pacific Cancer Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)

8.3. China

   8.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

   8.3.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

8.4. Japan

   8.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

   8.4.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

8.5. India

   8.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

   8.5.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

8.6. Australia

   8.6.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

   8.6.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

8.7. South Korea

   8.7.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

   8.7.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

8.8. Rest of Asia-Pacific

   8.8.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

   8.8.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)



CHAPTER 9. LATIN AMERICA CANCER THERAPEUTICS MARKET BY COUNTRY

9.1. Latin America Cancer Therapeutics Market Revenue and Growth Rate, 2015 - 2026 ($Million)

9.2. Latin America Cancer Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)

9.3. Brazil

   9.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

   9.3.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

9.4. Mexico

   9.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

   9.4.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

9.5. Rest of Latin America

   9.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

   9.5.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST & AFRICA CANCER THERAPEUTICS MARKET BY COUNTRY

10.1. Middle East & Africa Cancer Therapeutics Market Revenue and Growth Rate, 2015 - 2026 ($Million)

10.2. Middle East & Africa Cancer Therapeutics Market Revenue Share Comparison, 2015 & 2026 (%)

10.3. GCC

   10.3.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

   10.3.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

10.4. South Africa

   10.4.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

   10.4.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

10.5. Rest of Middle East & Africa

   10.5.1. Market Revenue and Forecast By Application, 2015 - 2026 ($Million)

   10.5.2. Market Revenue and Forecast By Treatment Type, 2015 - 2026 ($Million)

CHAPTER 11. COMPANY PROFILE

11.1. AbbVie Inc.

   11.1.1. Company Snapshot

   11.1.2. Overview

   11.1.3. Financial Overview

   11.1.4. Product Portfolio

   11.1.5. Key Developments

   11.1.6. Strategies

11.2. Astellas Pharma Inc.

   11.2.1. Company Snapshot

   11.2.2. Overview

   11.2.3. Financial Overview

   11.2.4. Product Portfolio

   11.2.5. Key Developments

   11.2.6. Strategies

11.3. Bristol Myers Squibb Company

   11.3.1. Company Snapshot

   11.3.2. Overview

   11.3.3. Financial Overview

   11.3.4. Product Portfolio

   11.3.5. Key Developments

   11.3.6. Strategies

11.4. Celgene Corporation

   11.4.1. Company Snapshot

   11.4.2. Overview

   11.4.3. Financial Overview

   11.4.4. Product Portfolio

   11.4.5. Key Developments

   11.4.6. Strategies

11.5. Eli Lilly and Company

   11.5.1. Company Snapshot

   11.5.2. Overview

   11.5.3. Financial Overview

   11.5.4. Product Portfolio

   11.5.5. Key Developments

   11.5.6. Strategies

11.6. F. Hoffmann-La Roche Ltd.

   11.6.1. Company Snapshot

   11.6.2. Overview

   11.6.3. Financial Overview

   11.6.4. Product Portfolio

   11.6.5. Key Developments

   11.6.6. Strategies

11.7. Johnson & Johnson

   11.7.1. Company Snapshot

   11.7.2. Overview

   11.7.3. Financial Overview

   11.7.4. Product Portfolio

   11.7.5. Key Developments

   11.7.6. Strategies

11.8. Merck & Co., Inc.

   11.8.1. Company Snapshot

   11.8.2. Overview

   11.8.3. Financial Overview

   11.8.4. Product Portfolio

   11.8.5. Key Developments

   11.8.6. Strategies

11.9. Novartis AG

   11.9.1. Company Snapshot

   11.9.2. Overview

   11.9.3. Financial Overview

   11.9.4. Product Portfolio

   11.9.5. Key Developments

   11.9.6. Strategies

11.10. Pfizer Inc.

   11.10.1. Company Snapshot

   11.10.2. Overview

   11.10.3. Financial Overview

   11.10.4. Product Portfolio

   11.10.5. Key Developments

   11.10.6. Strategies

11.11. Others

   11.11.1. Company Snapshot

   11.11.2. Overview

   11.11.3. Financial Overview

   11.11.4. Product Portfolio

   11.11.5. Key Developments

   11.11.6. Strategies

CHAPTER 12. RESEARCH APPROACH

12.1. Research Methodology

   12.1.1. Initial Data Search

   12.1.2. Secondary Research

   12.1.3. Primary Research

12.2. Assumptions and Scope



List of Figures

Reques Sample for List of Figures Figure


We can offer customized data and information to meet our clients need.

This report focuses on:

► Intelligent insights to take informed business decisions.

► Qualitative and quantitative analysis of the market.

► Market size and forecasts from 2024 to 2030.

► Opportunities for expansion and in-depth market analysis.

► Segmentation and regional revenue forecasts.

► Analysis of the market share and competitive landscape.

► Strategic recommendations for future growth.


You'll also receive:

► A comprehensive market research report in PDF or PPT formats.

► Access to our analysts to learn more about the report and get answers to your specific business questions.

► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.


Contact us today to learn more and get sample report.


Our Research Reports Look Like This
Pragma Market Research Sample

Covid-19 Impact Duns and Brad Badge
up